Pharma Course

Lesson 1 • Drug Development Lifecycle Overview

Traces a drug from discovery through post-market surveillance at a high level. Orients learners to the full pipeline before deep dives in later chapters.

Lesson 2 • Regulatory Bodies and Their Roles

Identifies major national and international regulatory agencies and their mandates. Establishes the compliance mindset required throughout the course.

Lesson 3 • Ethics and Patient-Centered Principles

Grounds industry practice in patient safety, informed consent, and ethical research conduct. Reinforces values that underpin every technical decision in the course.

Lesson 4 • Industry Overview and Market Structure

Maps the global pharma landscape including innovator, generic, and biotech segments. Provides context for all subsequent regulatory and commercial topics.

Lesson 1 • Preclinical Safety and Toxicology

Details in vitro and in vivo toxicology studies required before first-in-human trials. Links study design to regulatory submission requirements.

Lesson 2 • Target Identification and Validation

Covers genomic, proteomic, and phenotypic approaches to finding druggable targets. Connects biological rationale to downstream candidate selection decisions.

Lesson 3 • Hit-to-Lead and Lead Optimization

Explains high-throughput screening, structure-activity relationships, and ADMET profiling. Prepares learners to assess compound progression criteria.

Lesson 4 • Investigational New Drug Application Preparation

Outlines the data package needed to initiate clinical trials under regulatory oversight. Bridges preclinical science to the formal regulatory submission process.

Lesson 1 • Data Management and Safety Monitoring

Addresses electronic data capture, data cleaning, and data safety monitoring board functions. Links data integrity practices to regulatory submission quality.

Lesson 2 • Clinical Trial Phases and Objectives

Defines Phase I through Phase IV goals, endpoints, and population sizes. Provides the framework for all protocol design decisions covered in this chapter.

Lesson 3 • Good Clinical Practice Compliance

Details GCP principles, informed consent procedures, and audit readiness requirements. Ensures learners can maintain inspection-ready trial documentation.

Lesson 4 • Site Selection and Patient Recruitment

Covers investigator qualification, site feasibility, and recruitment strategy development. Connects operational planning to trial timeline and data quality outcomes.

Lesson 5 • Randomization, Blinding, and Controls

Explains randomization methods, blinding levels, and control arm selection to minimize bias. Reinforces scientific rigor required for regulatory acceptance.

Lesson 1 • Post-Approval Regulatory Obligations

Covers variation submissions, label updates, periodic safety reports, and risk management plans. Prepares learners for the ongoing regulatory workload after approval.

Lesson 2 • Clinical and Nonclinical Summary Writing

Teaches how to synthesize trial data into integrated summaries and overviews for regulators. Builds scientific writing skills critical for submission success.

Lesson 3 • Common Technical Document Structure

Explains the internationally harmonized dossier format used for drug applications. Provides the organizational framework for all submission content covered in this chapter.

Lesson 4 • New Drug Application Strategy

Covers standard and expedited approval pathways, pre-submission meetings, and labeling strategy. Enables learners to select the optimal regulatory pathway for a given product.

Lesson 1 • Manufacturing Process Development and Scale-Up

Covers process design, technology transfer, and scale-up from lab to commercial production. Links process understanding to product quality and regulatory filings.

Lesson 2 • Quality Control and Analytical Testing

Details in-process controls, release testing, and reference standard management. Ensures learners can oversee a compliant QC laboratory operation.

Lesson 3 • Good Manufacturing Practice Principles

Establishes GMP requirements for facilities, personnel, equipment, and documentation. Forms the compliance baseline for all manufacturing and quality topics.

Lesson 4 • Quality Management System Design

Explains CAPA, change control, deviation management, and document control systems. Provides the operational framework for a sustainable quality culture.

Lesson 1 • Pharmacovigilance System Fundamentals

Defines the scope, objectives, and legal basis of pharmacovigilance programs. Establishes the safety monitoring mindset required for all subsequent topics.

Lesson 2 • Signal Detection and Evaluation

Teaches quantitative and qualitative methods for identifying new safety signals from databases. Connects signal evaluation to benefit-risk decision-making.

Lesson 3 • Risk Management and Minimization

Details risk management plan development, additional risk minimization tools, and effectiveness evaluation. Prepares learners to design proportionate safety interventions.

Lesson 4 • Adverse Event Collection and Reporting

Covers spontaneous reporting, expedited reports, and aggregate safety reporting timelines. Builds operational skills for managing incoming safety data.

Lesson 1 • Product Launch Planning and Execution

Details launch readiness frameworks, cross-functional coordination, and key performance indicators. Connects regulatory approval to commercial activation milestones.

Lesson 2 • Ethical Promotion and Compliance

Covers promotional material review, off-label promotion risks, and industry code compliance. Ensures learners apply commercial strategies within regulatory boundaries.

Lesson 3 • Market Access Strategy Fundamentals

Defines payer landscape, health technology assessment processes, and value dossier development. Establishes the commercial framework built upon in later sections.

Lesson 4 • Pricing and Reimbursement Negotiation

Explains pricing strategy frameworks, reference pricing dynamics, and negotiation tactics with payers. Prepares learners for cross-functional pricing decisions.

Lesson 1 • Integrated Development Planning

Synthesizes regulatory, clinical, manufacturing, and commercial plans into a single integrated development plan. Culminates the course by connecting all prior chapters.

Lesson 2 • Portfolio Valuation and Prioritization

Applies net present value, risk-adjusted NPV, and scoring models to rank pipeline assets. Builds financial reasoning skills for senior development roles.

Lesson 3 • Licensing, Partnerships, and M&A

Explains in-licensing, out-licensing, co-development deals, and acquisition due diligence. Equips learners to evaluate external growth opportunities for a portfolio.

Lesson 4 • Development Risk Assessment and Mitigation

Identifies technical, regulatory, and commercial risks across the development lifecycle. Prepares learners to build contingency plans that protect program value.